AD-HIES
Showing 1 - 25 of 2,400
Genetics of Hyperimmunoglobulin E Recurrent Infection Syndrome
Recruiting
- Infections
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Skin Microbes in Healthy People and in People With Skin
Recruiting
- Atopic Dermatitis
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Immune-mediated Diseases
Recruiting
- Primary Immunodeficiency
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 10, 2023
Autosomal-dominant Hyper-IgE Syndrome Trial run by the NIAID (NDV-3A)
Terminated
- Autosomal-dominant Hyper-IgE Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 22, 2020
Atopic Dermatitis, Eczema Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Roseomonas mucosa
Not yet recruiting
- Atopic Dermatitis
- Eczema
- Roseomonas mucosa (RSM2015) and Cardamom seeds
- Placebo (sucrose)
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Atopic Dermatitis Trial
Not yet recruiting
- Atopic Dermatitis
- (no location specified)
Nov 16, 2023
Alzheimer's Disease (AD) Trial (SHR-1707 injection)
Not yet recruiting
- Alzheimer's Disease (AD)
- SHR-1707 injection
- (no location specified)
Nov 2, 2023
Alzheimer, Electric Stimulation Therapy Trial in Beijing (Cortical brain stimulation of mPFC and dlPFC)
Recruiting
- Alzheimer Disease
- Electric Stimulation Therapy
- Cortical brain stimulation of mPFC and dlPFC
-
Beijing, ChinaXuanwu Hospital
Jul 30, 2023
Alzheimer Trial in Houston (Choline)
Recruiting
- Alzheimer Disease
-
Houston, TexasThe University of Texas Health Science Center at Houston (UTHeal
May 25, 2023
Alzheimer, Mild Cognitive Impairment, Positron Emission Tomography Trial in Turku (FDG-PET study)
Recruiting
- Alzheimer Disease
- +2 more
- FDG-PET study
-
Turku, FinlandTurku PET Centre
Oct 30, 2023
Gut Microbiome and Blood Indices in AD and Their Spousal
Recruiting
- Alzheimer Disease
- Gut Biome
-
Charlottesville, VirginiaUniversity of Virginia
Jan 18, 2023
Alzheimer's Disease Trial in Worldwide (GSK4527226, Placebo)
Not yet recruiting
- Alzheimer's Disease
- GSK4527226
- Placebo
-
San Diego, California
- +99 more
Oct 6, 2023
DevelopingArtificial Intelligence System to Detect Cognitive
Recruiting
- Alzheimer Disease
- +2 more
-
Haifa, IsraelUniversity of Haifa
Mar 31, 2023
Alzheimer Trial in Brescia (real-rTMS, sham-rTMS)
Recruiting
- Alzheimer Disease
- real-rTMS
- sham-rTMS
-
Brescia, ItalyIRCCS Centro San Giovanni di Dio Fatebenefratelli
Aug 2, 2023
Dupilumab in Participants =6 Years With Atopic Dermatitis
Recruiting
- Atopic Dermatitis
-
Berlin, GermanyInvestigational Site Number :
Sep 18, 2023
Alzheimer's Disease Trial in Worldwide (BIIB092, Placebo)
Psychosis Associated With Alzheimer's Disease Trial in United States (KarXT, Placebo)
Recruiting
- Psychosis Associated With Alzheimer's Disease
- KarXT
- Placebo
-
Chandler, Arizona
- +15 more
Nov 8, 2023
Human Milk Oligosaccharides and Microbiomes on Infantile Colic
Recruiting
- Infantile Colic
- +3 more
-
Tainan, TaiwanNational Cheng Kung University & Hospital
Aug 7, 2023
The Swedish BioFINDER - Primary Care Study
Recruiting
- Mild Dementia
- +6 more
- Plasma APS 2 score
- +6 more
-
Malmö, SwedenPrimary care centers in Region Skåne
Nov 8, 2023
Tau Networks in Psychotic Alzheimer's Disease
Recruiting
- Alzheimer Disease
- +2 more
- [18F]-PI2620 PET scan
-
Manhasset, New YorkThe Feinstein Institutes for Medical Research
Apr 26, 2023
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
Recruiting
- Alzheimer Disease
- +4 more
-
Shanghai, Shanghai, ChinaRuijin Hospital, Shanghai Jiao Tong University School of Medicin
Oct 24, 2022
Canadian Patients Receiving Dupixent® for Moderate to Severe
Recruiting
- Moderate to Severe Atopic Dermatitis
-
Toronto, Ontario, Canada
- +1 more
Oct 24, 2023
Alzheimer Trial in Stanford (Bumetanide, Placebo)
Not yet recruiting
- Alzheimer Disease
- Bumetanide
- Placebo
-
Stanford, CaliforniaStanford University
Sep 18, 2023
Alzheimer Trial in Boston (High definition transcranial electrical current stimulation)
Not yet recruiting
- Alzheimer Disease
- High definition transcranial electrical current stimulation
-
Boston, Massachusetts677 Beacon St. Room 308
Oct 19, 2023
Alzheimer Trial in Beijing (XTR006)
Recruiting
- Alzheimer Disease
-
Beijing, Beijing Shi, ChinaChinese PLA General Hospital
Nov 21, 2023